News and Announcements
Analytica FY16 Update; Successful $2.4m Capital Raise, R&D on PeriCoach® System, International Case Studies Published
- Published July 06, 2016 10:56AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Analytica has had a productive 2016, including a successful $2.4m capital raise with a cornerstone investment from Innov8 LLC, and the appointment of Dr. Thomas Lönngren to the Board. The company is driving R&D work on the PeriCoach® System, aiming to provide game-changing functionality by the end of 2016. Case studies have been published in the internationally-recognised Urological Nurses Journal describing PeriCoach’s benefits.
The company is pursuing over-the-counter regulatory clearance in the US, where it is currently prescription-only. Our AutoStart Burette product has also been authorised for use by Queensland Health for use in all public hospitals.
ABOUT ANALYTICA LTD
Analytica Limited (ASX:ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.
PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
